Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1965 2
1966 1
1967 1
1969 4
1970 2
1971 1
1972 2
1974 1
1976 1
1977 2
1979 4
1982 1
1983 2
1985 2
1987 1
1989 2
1990 1
1993 3
1994 1
1995 1
1996 2
1998 1
1999 6
2000 2
2001 2
2002 3
2003 2
2004 4
2005 2
2007 3
2010 1
2011 3
2012 3
2013 3
2014 6
2015 6
2016 3
2017 6
2018 7
2019 5
2020 7
2021 11
2022 5
2023 3
2024 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

128 results

Results by year

Filters applied: . Clear all
Page 1
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
Behr J, Prasse A, Kreuter M, Johow J, Rabe KF, Bonella F, Bonnet R, Grohe C, Held M, Wilkens H, Hammerl P, Koschel D, Blaas S, Wirtz H, Ficker JH, Neumeister W, Schönfeld N, Claussen M, Kneidinger N, Frankenberger M, Hummler S, Kahn N, Tello S, Freise J, Welte T, Neuser P, Günther A; RELIEF investigators. Behr J, et al. Lancet Respir Med. 2021 May;9(5):476-486. doi: 10.1016/S2213-2600(20)30554-3. Epub 2021 Mar 30. Lancet Respir Med. 2021. PMID: 33798455 Clinical Trial.
Peripheral Serotonin Synthesis as a New Drug Target.
Matthes S, Bader M. Matthes S, et al. Trends Pharmacol Sci. 2018 Jun;39(6):560-572. doi: 10.1016/j.tips.2018.03.004. Epub 2018 Apr 5. Trends Pharmacol Sci. 2018. PMID: 29628275 Review.
Structure-Based Design of Xanthine-Imidazopyridines and -Imidazothiazoles as Highly Potent and In Vivo Efficacious Tryptophan Hydroxylase Inhibitors.
Specker E, Wesolowski R, Schütz A, Matthes S, Mallow K, Wasinska-Kalwa M, Winkler L, Oder A, Alenina N, Pleimes D, von Kries JP, Heinemann U, Bader M, Nazaré M. Specker E, et al. Among authors: matthes s. J Med Chem. 2023 Nov 9;66(21):14866-14896. doi: 10.1021/acs.jmedchem.3c01454. Epub 2023 Oct 31. J Med Chem. 2023. PMID: 37905925
Phenylalanine hydroxylase contributes to serotonin synthesis in mice.
Mordhorst A, Dhandapani P, Matthes S, Mosienko V, Rothe M, Todiras M, Self J, Schunck WH, Schütz A, Bader M, Alenina N. Mordhorst A, et al. Among authors: matthes s. FASEB J. 2021 Jun;35(6):e21648. doi: 10.1096/fj.202100366R. FASEB J. 2021. PMID: 33993565
Community-Wide Experimental Evaluation of the PROSS Stability-Design Method.
Peleg Y, Vincentelli R, Collins BM, Chen KE, Livingstone EK, Weeratunga S, Leneva N, Guo Q, Remans K, Perez K, Bjerga GEK, Larsen Ø, Vaněk O, Skořepa O, Jacquemin S, Poterszman A, Kjær S, Christodoulou E, Albeck S, Dym O, Ainbinder E, Unger T, Schuetz A, Matthes S, Bader M, de Marco A, Storici P, Semrau MS, Stolt-Bergner P, Aigner C, Suppmann S, Goldenzweig A, Fleishman SJ. Peleg Y, et al. Among authors: matthes s. J Mol Biol. 2021 Jun 25;433(13):166964. doi: 10.1016/j.jmb.2021.166964. Epub 2021 Mar 27. J Mol Biol. 2021. PMID: 33781758 Free PMC article.
128 results